COVID-19 Amplification Control
The A2K COVID-19 Amplification Control is a plasmid containing the complete nucleocapsid gene from 2019-nCoV. It can be used as a positive control for the A2K COVID-19 DirectAmp PCR Assay, or as a stand-alone sample to verify assay performance and to help with troubleshooting.
Why the COVID-19 Amplification Control
A precisely quantified positive control
Each lot of the COVID-19 Amplification Control is quantified to 2 x 10⁵ copies/µL, giving your lab a consistent, known-concentration reference for every qPCR run.
Targets both nucleocapsid gene regions
The control plasmid contains the complete nucleocapsid gene from 2019-nCoV, covering both the N1 and N2 target regions used in the A2K COVID-19 DirectAmp PCR Assay.
Built to pair with the DirectAmp workflow
Use it as a positive control for the A2K COVID-19 DirectAmp PCR Assay, or as a stand-alone sample to verify assay performance and help with troubleshooting.
Convenient, ready-to-use format
Supplied as a 250 µL ready-to-use plasmid stock, so there's no reconstitution step before adding it to your run.
- SKU
- CTRL-CV19